Research ArticleDiets rich in fructose, fat or fructose and fat alter intestinal barrier function and lead to the development of nonalcoholic fatty liver disease over time☆,☆☆
Introduction
Nonalcoholic fatty liver disease (NAFLD) is a disease comprising a continuum of liver damage ranging from simple steatosis to nonalcoholic steatohepatitis (NASH) and cirrhosis. A recent survey reviewing 260 epidemiological studies published in Europe in the last 5 years reported that NAFLD has to be accounted to the most frequent liver diseases in Europe [1]. Furthermore, results of Vernon et al. even suggest that NAFLD is the most common cause of elevated liver enzymes worldwide [2]. Also, it has been suggested that fatty livers, long thought to be a benign state of liver disease, are more vulnerable to injury from various causes increasing the probability to progress to later stages of the disease and further liver-related morbidity and mortality [3], [4]. However, despite intense research efforts during the last decades, molecular and pathological changes involved in the onset and even more so the progression of NAFLD are not yet fully understood and therapeutic options are still rather limited. Therefore, a better understanding of the alterations causally involved in the early stages of NAFLD is desirable to improve prevention and intervention strategies.
General overnutrition, particularly when being rich in fat and/or sugars like fructose, is being discussed to be key factors in the development of NAFLD [5]. However, results of not only animal-based studies but also some human studies suggest that not only the development of NAFLD in settings of overnutrition may result from the extra energy adding to an enhanced de novo synthesis and storage of lipids but also other factors may be involved. Indeed, we showed that the development of NAFLD in mice chronically fed a fructose-rich diet is associated with increased endotoxin levels in portal blood and an activation of the toll-like receptor TLR-dependent signaling cascades [6], [7]. Similar findings were also reported form NAFLD models exposing animals chronically to a high-fat diet [8], [9]. It was further shown that chronic intake of fat and fructose, respectively, is associated with a decrease in tight junction proteins in the small intestine [10], [11]. However, if the combination of a chronic exposure to a fat- and fructose-rich diet has an additive or even synergistic effect on the loss of tight junctions, the increased permeation of bacterial endotoxin and subsequently the development of liver damage and if these effects progress with time have not yet been systematically studied. Starting from this background, the aim of our study was to assess the effects of a chronic intake of a fructose, fat or fructose- and fat-enriched diet on intestinal tight junction proteins, portal endotoxin levels and the development of NAFLD over time in mice.
Section snippets
Animals and treatment
Six- to eight-week-old female C57BL/6J mice (Janvier Labs, Le Genest-Saint-Isle, France), shown before to be more susceptible to fructose-induced NAFLD than male mice [12], were housed in a specified and opportunistic pathogen-free (SOPF) barrier facility accredited by the Association for Assessment and Accreditation of Laboratory Animal Care. All procedures were approved by the local Institutional Animal Care and Use Committee. Mice (n=6 per group) had free access to plain tap water and
Effect of a diet rich in fructose, fat or fat and fructose on caloric intake and body weight
In Table 1 and Fig. 1A and B, intake of the different diets as well as body weight gain throughout the 8 and 16 weeks long feeding period, respectively, is summarized. Caloric intake and absolute body weight gain of mice fed standard chow and plain water did not differ from that of mice fed the high-fat diet. In line with earlier reports of our group [13], mice fed a 30% fructose solution reduced their caloric intake from chow significantly by ~45% in comparison to mice fed a standard chow.
Discussion
Worldwide, the number of individuals affected by NAFLD is still increasing. Results of several human studies suggest that lifestyle and herein particular physical activity and overnutrition are critical [5], [19]; however, in more recent years, it has been suggested that not only a general overnutrition but also dietary composition may be critical [20]. Indeed, epidemiological studies suggest that a diet rich in fat and cholesterol may increase the odds to develop NAFLD [21]. Similar data have
Conclusion
Taken together, our data suggest that chronic intake of fat, fructose and even more so a combined intake of fat and fructose leads to the development of NAFLD in mice, which progresses with time of intake. Our data further suggest that the development of NAFLD in feeding models using fat, fructose or a combination of both is associated with impairments of intestinal barrier function and an activation of TLR-4-dependent signaling cascades in the liver. However, further studies are needed to
Conflict of Interest
The authors declare that they have no competing interests or other interests that might be perceived to influence the results and discussion reported in this paper.
Acknowledgements
This work is funded by grants from Bundesministerium für Bildung und Forschung, FKZ: 01EA1305 and FKZ: 01KU1214A (both IB).
References (47)
- et al.
The burden of liver disease in Europe: a review of available epidemiological data
J Hepatol
(2013) - et al.
DSS induced colitis increases portal LPS levels and enhances hepatic inflammation and fibrogenesis in experimental NASH
J Hepatol
(2011) - et al.
Protective effect of bile acids on the onset of fructose-induced hepatic steatosis in mice
J Lipid Res
(2010) - et al.
Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: role of endotoxin
J Hepatol
(2008) Histopathology of non-alcoholic fatty liver disease
Clin Liver Dis
(2009)- et al.
Metformin protects against the development of fructose-induced steatosis in mice: role of the intestinal barrier function
Lab Invest
(2012) - et al.
Cinnamon extract protects against acute alcohol-induced liver steatosis in mice
J Nutr
(2009) - et al.
Fructose consumption as a risk factor for non-alcoholic fatty liver disease
J Hepatol
(2008) - et al.
Bifidobacterium adolescentis protects from the development of nonalcoholic steatohepatitis in a mouse model
J Nutr Biochem
(2014) - et al.
Effect of dietary fats and fatty acids on the liver lipid accumulation induced by feeding a protein-repletion diet containing fructose to protein-depleted rats
J Nutr
(1974)
Berberine reduces insulin resistance through protein kinase C-dependent up-regulation of insulin receptor expression
Metabolism
Chylomicrons promote intestinal absorption of lipopolysaccharides
J Lipid Res
Chylomicron-bound LPS selectively inhibits the hepatocellular response to proinflammatory cytokines
J Surg Res
M2 kupffer cells promote hepatocyte senescence: an IL-6-dependent protective mechanism against alcoholic liver disease
Am J Pathol
Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults
Aliment Pharmacol Ther
Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study
Hepatology
Epidemiology and natural history of patients with NAFLD
Curr Pharm Des
Role of diet and nutritional management in non-alcoholic fatty liver disease
J Gastroenterol Hepatol
Toll-like receptors 1–9 are elevated in livers with fructose-induced hepatic steatosis
Br J Nutr
Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice
Hepatology
Toll-like receptor-4 mediates obesity-induced non-alcoholic steatohepatitis through activation of X-box binding protein-1 in mice
Gut
Dietary fat and bile juice, but not obesity, are responsible for the increase in small intestinal permeability induced through the suppression of tight junction protein expression in LETO and OLETF rats
Nutr Metab (Lond)
Female mice are more susceptible to nonalcoholic fatty liver disease: sex-specific regulation of the hepatic AMP-activated protein kinase-plasminogen activator inhibitor 1 cascade, but not the hepatic endotoxin response
Mol Med
Cited by (132)
Fructose dose-dependently influences colon barrier function by regulation of some main physical, immune, and biological factors in rats
2024, Journal of Nutritional BiochemistryGut-liver axis: Pathophysiological concepts and medical perspective in chronic liver diseases
2024, Seminars in ImmunologyAntibiotics attenuate diet-induced nonalcoholic fatty liver disease without altering intestinal barrier dysfunction
2024, Journal of Nutritional BiochemistryFructose impairs fat oxidation: Implications for the mechanism of western diet-induced NAFLD
2023, Journal of Nutritional Biochemistry
- ☆
Funded by grants from Bundesministerium für Bildung und Forschung, FKZ: 01EA1305 and FKZ: 01KU1214A (both IB).
- ☆☆
Conflicts of interest: None.